Advances in microscopy and complementary imaging techniques to assess the fate of drugs ex vivo in respiratory drug delivery. An invited paper

Advanced Drug Delivery Reviews

Volumn 64, Issue 4, 2012, Pages 344-356

  Park, Chun Woong ^a   Rhee, Yun Seok ^b   Vogt, Frederick G ^c   Hayes, Don ^d   Zwischenberger, Joseph B ^a   DeLuca, Patrick P ^a   Mansour, Heidi M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Gyeongsang National University   (South Korea)

^c GLAXOSMITHKLINE   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Chemical imaging; Confocal Raman microspectroscopy; Ex vivo; In vivo; Multimodal multifunctional imaging; Non optical imaging; Optical imaging; Targeted pulmonary delivery

Indexed keywords

CHEMICAL IMAGING; CONFOCAL RAMAN MICROSPECTROSCOPY; EX-VIVO; IN VIVO; MULTI-MODAL; OPTICAL IMAGING; PULMONARY DELIVERY;

CONFOCAL MICROSCOPY; DRUG DELIVERY; MAGNETIC RESONANCE IMAGING; OPTICAL IMAGE STORAGE; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

POSITRON EMISSION TOMOGRAPHY;

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; CLARITHROMYCIN; CLENBUTEROL; DOXORUBICIN; FLUORESCEIN; INDOCYANINE GREEN; OLIGONUCLEOTIDE; PORPHYRIN DERIVATIVE; RESPIRATORY TRACT AGENT; VANCOMYCIN;

BIOLUMINESCENCE IMAGING; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONFOCAL MICROSCOPY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRY POWDER; EX VIVO STUDY; FLUORESCENCE IMAGING; HUMAN; HYPOXIA; ISOTOPE LABELING; LUNG ALVEOLUS CELL; LUNG PARENCHYMA; MICROSCOPE; MOLECULAR IMAGING; MULTIPHOTON MICROSCOPY; NANOPHARMACEUTICS; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REVIEW; SCINTILLATION CAMERA; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPRAY DRYING;

ANIMALS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; MICROSCOPY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; RESPIRATORY SYSTEM;

EID: 84858621131     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.08.004     Document Type: Review

References (159)

1. Rolle A., Koch R., Alpard S.K., Zwischenberger J.B. Lobe-sparing resection of multiple pulmonary metastases with a new 1318-nm Nd: YAG laser-first 100 patients. Ann. Thorac. Surg. 2002, 74:865-869.
2. Savage C., Zwischenberger J.B. Image-guided fine needle aspiration strategies for staging of lung cancer. Clin. Lung Cancer 2000, 2:101-110.
3. Hickey A.J., Mansour H.M. Formulation challenges of powders for the delivery of small molecular weight molecules as aerosols. Modified-Release Drug Delivery Technology 2008, 573-602. Informa Healthcare, New york.
4. Hickey A.J., Mansour H.M. Delivery of drugs by the pulmonary route. Modern Pharmaceutics 2009, 191-219. Informa Healthcare, New York.
5. Mansour H.M., Rhee Y.S., Wu X. Nanomedicine in pulmonary delivery. Int. J. Nanomedicine 2009, 4:299-319.
6. Hoffman A., Goetz M., Vieth M., Galle P.R., Neurath M.F., Kiesslich R. Confocal laser endomicroscopy: technical status and current indications. Endoscopy 2006, 38:1275-1283.
7. Minsky M. Memoir on inventing the confocal scanning microscope. Scanning 1988, 10:128-138.
8. Balas C. Review of biomedical optical imaging-a powerful, non-invasive, non-ionizing technology for improving in vivo diagnosis. Measure. Sci. Technol. 2009, 20:1-12.
9. Schmolze D.B., Standley C., Fogarty K.E., Fischer A.H. Advances in microscopy techniques. Arch. Pathol. Lab. Med. 2011, 135:255-263.
10. Buranachai C., Kamiyama D., Chiba A., Williams B., Clegg R. Rapid frequency-domain FLIM spinning disk confocal microscope: lifetime resolution. image improvement and wavelet analysis. J. Fluoresc. 2008, 18:929-942.
11. St.Croix C.M., Leelavanichkul K., Watkins S.C. Intravital fluorescence microscopy in pulmonary research. Adv. Drug Deliv. Rev. 2006, 58:834-840.
12. Salaun M., Roussel F., Hauss P., Lachkar S., Thiberville L. In vivo imaging of pulmonary alveolar proteinosis using confocal endomicroscopy. Eur. Respir. J. 2010, 36:451.
13. Fuchs F.S., Zirlik S., Hildner K., Frieser M., Ganslmayer M., Schwarz S., Uder M., Neurath M.F. Fluorescein-aided confocal laser endomicroscopy of the lung. Respiration 2010.
14. Nava R.G., Li W., Gelman A.E., Krupnick A.S., Miller M.J., Kreisel D. Two-photon microscopy in pulmonary research 2010, 1-8. Springer.
15. Thiberville L., Salaun M., Lachkar S., Dominique S., Moreno-Swirc S., Vever-Bizet C., Bourg-Heckly G. Confocal fluorescence endomicroscopy of the human airways. Am Thoracic Soc 2009, 444.
16. De Koker S., Naessens T., De Geest B.G., Bogaert P., Demeester J., De Smedt S., Grooten J. Biodegradable polyelectrolyte microcapsules: antigen delivery tools with Th17 skewing activity after pulmonary delivery. J. Immunol. 2010, 184:203.
17. Ortner A., Wernig K., Kaisler R., Edetsberger M., Hajos F., Kohler G., Mosgoeller W., Zimmer A. VPAC receptor mediated tumor cell targeting by protamine based nanoparticles. J. Drug Target. 2010, 1-11.
18. Yang Y., Bajaj N., Xu P., Ohn K., Tsifansky M.D., Yeo Y. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 2009, 30:1947-1953.
19. Taetz S., Nafee N., Beisner J., Piotrowska K., Baldes C., Murdter T., Huwer H., Schneider M., Schaefer U., Klotz U. The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells. Eur. J. Pharm. Biopharm. 2009, 72:358-369.
20. Ungaro F., d'Emmanuele di Villa Bianca R., Giovino C., Miro A., Sorrentino R., Quaglia F., La Rotonda M.I. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J. Control. Release 2009, 135:25-34.
21. Tahara K., Sakai T., Yamamoto H., Takeuchi H., Hirashima N., Kawashima Y. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int. J. Pharm. 2009, 382:198-204.
22. Kim H., Park H., Lee J., Kim T.H., Lee E.S., Oh K.T., Lee K.C., Youn Y.S. Highly porous large poly (lactic-co-glycolic acid) microspheres adsorbed with palmityl-acylated exendin-4 as a long-acting inhalation system for treating diabetes. Biomaterials 2010.
23. Garbuzenko O.B., Saad M., Betigeri S., Zhang M., Vetcher A.A., Soldatenkov V.A., Reimer D.C., Pozharov V.P., Minko T. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug. Pharm. Res. 2009, 26:382-394.
24. Wijagkanalan W., Kawakami S., Takenaga M., Igarashi R., Yamashita F., Hashida M. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J. Control. Release 2008, 125:121-130.
25. Beisner J., Dong M., Taetz S., Piotrowska K., Kleideiter E., Friedel G., Schaefer U., Lehr C.M., Klotz U., Murdter T.E. Efficient telomerase inhibition in human non small cell lung cancer cells by liposomal delivery of 2¡Ç O methyl RNA. J. Pharm. Sci. 2009, 98:1765-1774.
26. Grosse S., Thevenot G., Aron Y., Duverger E., Abdelkarim M., Roche A.C., Monsigny M., Fajac I. In vivo gene delivery in the mouse lung with lactosylated polyethylenimine, questioning the relevance of in vitro experiments. J. Control. Release 2008, 132:105-112.
27. Jere D., Jiang H.L., Kim Y.K., Arote R., Choi Y.J., Yun C.H., Cho M.H., Cho C.S. Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells. Int. J. Pharm. 2009, 378:194-200.
28. Nassimi M., Schleh C., Lauenstein H., Hussein R., Hoymann H., Koch W., Pohlmann G., Krug N., Sewald K., Rittinghausen S. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur. J. Pharm. Biopharm. 2010, 75:107-116.
29. Li Y.Z., Sun X., Gong T., Liu J., Zuo J., Zhang Z.R. Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles. Pharm. Res. 2010, 1-10.
30. Nassimi M., Schleh C., Lauenstein H.D., Hussein R., Lubbers K., Pohlmann G., Switalla S., Sewald K., Muller M., Krug N. Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models. Inhal. Toxicol. 2009, 21:104-109.
31. Patlolla R.R., Chougule M., Patel A.R., Jackson T., Tata P.N.V., Singh M. Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. J. Control. Release 2010, 144:233-241.
32. Surti N., Misra A. Wheat germ agglutinin-conjugated nanoparticles for sustained cellular and lung delivery of budesonide. Drug Deliv. 2008, 15:81-86.
33. Beisner J., Dong M., Taetz S., Nafee N., Griese E.U., Schaefer U., Lehr C.M., Klotz U., Murdter T.E. Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells. Lung Cancer 2010, 68:346-354.
34. Tseng C.L., Wang T.W., Dong G.C., Yueh-Hsiu Wu S., Young T.H., Shieh M.J., Lou P.J., Lin F.H. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials 2007, 28:3996-4005.
35. Yang Y.T., Chen C.T., Yang J.C., Tsai T. Spray-dried microparticles containing polymeric micelles encapsulating hematoporphyrin. AAPS J. 2010, 12:138-146.
36. Morris C.J., Smith M.W., Griffiths P.C., McKeown N.B., Gumbleton M. Enhancing the pulmonary absorption of a macromolecule through coupling to a phage display-derived peptide: a study in Isolated perfused rat lung. J. Control. Release 2010.
37. Amidi M., Pellikaan H.C., de Boer A.H., Crommelin D.J.A., Hennink W.E., Jiskoot W. Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery. Eur. J. Pharm. Biopharm. 2008, 68:191-200.
38. Denk W., Strickler J.H., Webb W.W. Two-photon laser scanning fluorescence microscopy. Science 1990, 248:73.
39. Diaspro A. Confocal and two-photon microscopy: foundations, applications, and advances 2002, Wiley-Liss, New York.
40. Amornphimoltham P. Intravital microscopy as a tool to study drug delivery in preclinical studies. Adv. Drug Deliv. Rev. 2010.
41. Rubart M. Two-photon microscopy of cells and tissue. Circ. Res. 2004, 95:1154-1166.
42. Denk W., Strickler J.H., Webb W.W. Two-photon laser scanning fluorescence microscopy. Science 1990, 248:73-76.
43. Zipfel W.R., Williams R.M., Webb W.W. Nonlinear magic: multiphoton microscopy in the biosciences. Nat. Biotechnol. 2003, 21:1369-1377.
44. Oheim M., Michael D.J., Geisbauer M., Madsen D., Chow R.H. Principles of two-photon excitation fluorescence microscopy and other nonlinear imaging approaches. Adv. Drug Deliv. Rev. 2006, 58:788-808.
45. Bullen A. Microscopic imaging techniques for drug discovery. Nat. Rev. Drug Discov. 2008, 7:54-67.
46. Konig K. Multiphoton microscopy in life sciences. J. Microsc. 2000, 200:83-104.
47. Masters B.R., So P.T.C. Handbook of biomedical nonlinear optical microscopy 2008, Oxford University Press, USA.
48. Gibson E.A., Masihzadeh O., Lei T.C., Ammar D.A., Kahook M.Y. Multiphoton Microscopy for Ophthalmic Imaging. J. Ophthalmol. 2011.
49. Bestvater F., Spiess E., Stobrawa G., Hacker M., Feurer T., Porwol T., Berchner Pfannschmidt U., Wotzlaw C., Acker H. Two photon fluorescence absorption and emission spectra of dyes relevant for cell imaging. J. Microsc. 2002, 208:108-115.
50. Spiess E., Bestvater F., Heckel-Pompey A., Toth K., Hacker M., Stobrawa G., Feurer T., Wotzlaw C., Pfannschmidt U.Berchner, Porwol T. Two photon excitation and emission spectra of the green fluorescent protein variants ECFP, EGFP and EYFP. J. Microsc. 2005, 217:200-204.
51. Bao H., Boussioutas A., Jeremy R., Russell S., Gu M. Second harmonic generation imaging via nonlinear endomicroscopy. Opt. Express 2010, 18:1255-1260.
52. Mertz J. Nonlinear microscopy: new techniques and applications. Curr. Opin. Neurobiol. 2004, 14:610-616.
53. Campagnola P.J., Loew L.M. Second-harmonic imaging microscopy for visualizing biomolecular arrays in cells, tissues and organisms. Nat. Biotechnol. 2003, 21:1356-1360.
54. Muller M., Squier I., Wilson K., Brakenhoff G. 3D microscopy of transparent objects using third-harmonic generation. J. Microsc. 1998, 191:266-274.
55. Debarre D., Supatto W., Pena A.M., Fabre A., Tordjmann T., Combettes L., Schanne-Klein M.C., Beaurepaire E. Imaging lipid bodies in cells and tissues using third-harmonic generation microscopy. Nat. Methods 2005, 3:47-53.
56. Squier J., Muller M., Brakenhoff G., Wilson K.R. Third harmonic generation microscopy. Opt. Express 1998, 3:315-324.
57. Yelin D., Silberberg Y. Laser scanning third-harmonic-generation microscopy in biology. Opt. Express 1999, 5:169-175.
58. Evans C.L., Xie X.S. Coherent anti-Stokes Raman scattering microscopy: chemical imaging for biology and medicine. Annu. Rev. Anal. Chem. 2008, 1:883-909.
59. Chan J., Fore S., Wachsmann Hogiu S., Huser T. Raman spectroscopy and microscopy of individual cells and cellular components. Laser Photon. Rev. 2008, 2:325-349.
60. Mansour H.M., Hickey A.J. Raman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a review. AAPS PharmSciTech 2007, 8:140-155.
61. Volkmer A. Coherent Raman scattering microscopy. Emerging Raman Applications and Techniques in Biomedical and Pharmaceutical Fields 2010, 111-152. Springer, New York. P. Matousek, M.D. Morris (Eds.).
62. Murugkar S., Evans C., Xie X., Anis H. Chemically specific imaging of cryptosporidium oocysts using coherent anti Stokes Raman scattering (CARS) microscopy. J. Microsc. 2009, 233:244-250.
63. Wang H., Fu Y., Zickmund P., Shi R., Cheng J.X. Coherent anti-Stokes Raman scattering imaging of axonal myelin in live spinal tissues. Biophys. J. 2005, 89:581-591.
64. Fu Y., Wang H., Huff T.B., Shi R., Cheng J.X. Coherent anti stokes Raman scattering imaging of myelin degradation reveals a calcium dependent pathway in lyso PtdCho induced demyelination. J. Neurosci. Res. 2007, 85:2870-2881.
65. Lim R.S., Kratzer A., Barry N.P., Miyazaki-Anzai S., Miyazaki M., Mantulin W.W., Levi M., Potma E.O., Tromberg B.J. Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice. J. Lipid Res. 2010, 51:1729.
66. Gelman A.E., Li W., Richardson S.B., Zinselmeyer B.H., Lai J., Okazaki M., Kornfeld C.G., Kreisel F.H., Sugimoto S., Tietjens J.R. Cutting edge: acute lung allograft rejection is independent of secondary lymphoid organs. J. Immunol. 2009, 182:3969.
67. Pena A.M., Fabre A., Debarre D., Marchal-Somme J., Crestani B., Martin J.L., Beaurepaire E., Schanne-Klein M.C. Three-dimensional investigation and scoring of extracellular matrix remodeling during lung fibrosis using multiphoton microscopy. Microsc. Res. Tech. 2007, 70:162.
68. Wang C.C., Wu R., Lin S.J., Chen Y.F., Dong C.Y. Label-free discrimination of normal and pulmonary cancer tissues using multiphoton fluorescence ratiometric microscopy. Appl. Phys. Lett. 2010, 97. 043706-043706-043703.
69. Bhirde A.A., Patel V., Gavard J., Zhang G., Sousa A.A., Masedunskas A., Leapman R.D., Weigert R., Gutkind J.S., Rusling J.F. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009, 3:307-316.
70. Takemoto H., Ishii A., Miyata K., Nakanishi M., Oba M., Ishii T., Yamasaki Y., Nishiyama N., Kataoka K. Polyion complex stability and gene silencing efficiency with a siRNA-grafted polymer delivery system. Biomaterials 2010.
71. Dziubla T.D., Shuvaev V.V., Hong N.K., Hawkins B.J., Madesh M., Takano H., Simone E., Nakada M.T., Fisher A., Albelda S.M. Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. Biomaterials 2008, 29:215-227.
72. Kortylewski M., Swiderski P., Herrmann A., Wang L., Kowolik C., Kujawski M., Lee H., Scuto A., Liu Y., Yang C. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat. Biotechnol. 2009, 27:925-932.
73. Liu Z., Kiessling F., Gatjens J. Advanced nanomaterials in multimodal imaging: design, functionalization, and biomedical applications. J. Nanomater. 2010, 2010:51.
74. Ntziachristos V. Fluorescence molecular imaging. Annu. Rev. Biomed. Eng. 2006, 8:1-33.
75. Bugaj J.E., Achilefu S., Dorshow R.B., Rajagopalan R. Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. J. Biomed. Opt. 2001, 6:122.
76. Dothager R.S., Flentie K., Moss B., Pan M.H., Kesarwala A., Piwnica-Worms D. Advances in bioluminescence imaging of live animal models. Curr. Opin. Biotechnol. 2009, 20:45-53.
77. Sadikot R.T., Blackwell T.S. Bioluminescence imaging. Am Thoracic Soc 2005, 537.
78. De Wet J.R., Wood K.V., Helinski D.R., DeLuca M. Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:7870.
79. Nguyen V.T., Morange M., Bensaude O. Firefly luciferase luminescence assays using scintillation counters for quantitation in transfected mammalian cells. Anal. Biochem. 1988, 171:404-408.
80. Lipshutz G.S., Gruber C.A., Cao Y., Hardy J., Contag C.H., Gaensler K.M.L. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol. Ther. 2001, 3:284-292.
81. Luker K.E., Luker G.D. Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation. Antiviral Res. 2008, 78:179-187.
82. Sutton E.J., Henning T.D., Pichler B.J., Bremer C., Daldrup-Link H.E. Cell tracking with optical imaging. Eur. Radiol. 2008, 18:2021-2032.
83. Willmann J.K., Van Bruggen N., Dinkelborg L.M., Gambhir S.S. Molecular imaging in drug development. Nat. Rev. Drug Discov. 2008, 7:591-607.
84. Dothager R.S., Piwnica-Worms D. Molecular imaging of pulmonary disease in vivo. Am Thoracic Soc 2009, 403.
85. Edinger M., Cao Y.A., Verneris M.R., Bachmann M.H., Contag C.H., Negrin R.S. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 2003, 101:640.
86. Moss B.L., Gross S., Gammon S.T., Vinjamoori A., Piwnica-Worms D. Identification of a ligand-induced transient refractory period in nuclear factor-êB signaling. J. Biol. Chem. 2008, 283:8687.
87. Mizuno T., Mohri K., Nasu S., Danjo K., Okamoto H. Dual imaging of pulmonary delivery and gene expression of dry powder inhalant by fluorescence and bioluminescence. J. Control. Release 2009, 134:149-154.
88. Mohri K., Okuda T., Mori A., Danjo K., Okamoto H. Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation. J. Control. Release 2010, 144:221-226.
89. Griesenbach U., Meng C., Farley R., Cheng S.H., Scheule R.K., Davies M.H., Wolstenholme-Hogg P.C., Ten Hove W., van der Hoeven P., Sinn P.L. In vivo imaging of gene transfer to the respiratory tract. Biomaterials 2008, 29:1533-1540.
90. Garbuzenko O.B., Saad M., Pozharov V.P., Reuhl K.R., Mainelis G., Minko T. Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proc. Natl. Acad. Sci. 2010, 107:10737.
91. Elfinger M., Geiger J., Hasenpusch G., Uzgun S., Sieverling N., Aneja M.K., Maucksch C., Rudolph C. Targeting of the [beta] 2-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo. J. Control. Release 2009, 135:234-241.
92. Oros A.M., Shah N.J. Hyperpolarized xenon in NMR and MRI. Phys. Med. Biol. 2004, 49:R105.
93. Leach M. Magnetic resonance spectroscopy (MRS) in the investigation of cancer at The Royal Marsden Hospital and The Institute of Cancer Research. Phys. Med. Biol. 2006, 51:R61.
94. Sosnovik D., Weissleder R. Magnetic resonance and fluorescence based molecular imaging technologies. Imaging in Drug Discovery and Early Clinical Trials 2005, 83-115.
95. Frank J.A., Zywicke H., Jordan E., Mitchell J., Lewis B.K., Miller B., Bryant L.H., Bulte J. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad. Radiol. 2002, 9:S484.
96. Kraitchman D.L., Heldman A.W., Atalar E., Amado L.C., Martin B.J., Pittenger M.F., Hare J.M., Bulte J.W.M. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107:2290.
97. Van Beek E.J.R., Wild J.M., Kauczor H.U., Schreiber W., Mugler J.P., De Lange E.E. Functional MRI of the lung using hyperpolarized 3 helium gas. J. Magn. Reson. Imaging 2004, 20:540-554.
98. Lipson D.A., Roberts D.A., Hansen Flaschen J., Gentile T.R., Jones G., Thompson A., Dimitrov I.E., Palevsky H.I., Leigh J.S., Schnall M. Pulmonary ventilation and perfusion scanning using hyperpolarized helium 3 MRI and arterial spin tagging in healthy normal subjects and in pulmonary embolism and orthotopic lung transplant patients. Magn. Reson. Med. 2002, 47:1073-1076.
99. Suga K., Yuan Y., Ogasawara N., Tsukuda T., Matsunaga N. Altered clearance of gadolinium diethylenetriaminepentaacetic acid aerosol from bleomycin-injured dog lungs: initial observations. Am. J. Respir. Crit. Care Med. 2003, 167:1704.
100. Suga K., Ogasawara N., Tsukuda T., Matsunaga N. Assessment of regional lung ventilation in dog lungs with Gd DTPA aerosol ventilation MR imaging. Acta Radiol. 2002, 43:282-291.
101. Plathow C., Fink C., Ley S., Puderbach M., Eichinger M., Zuna I., Schmahl A., Kauczor H.U. Measurement of tumor diameter-dependent mobility of lung tumors by dynamic MRI. Radiother. Oncol. 2004, 73:349-354.
102. Weissleder R., Moore A., Mahmood U., Bhorade R., Benveniste H., Chiocca E.A., Basilion J.P. In vivo magnetic resonance imaging of transgene expression. Nat. Med. 2000, 6:351-354.
103. Guthi J.S., Yang S.G., Huang G., Li S., Khemtong C., Kessinger C.W., Peyton M., Minna J.D., Brown K.C., Gao J. MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. Mol. Pharm. 2009, 7:32-40.
104. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J.S., Chin S.F., Sherry A.D., Boothman D.A., Gao J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006, 6:2427-2430.
105. Paulus M.J., Gleason S.S., Kennel S.J., Hunsicker P.R., Johnson D.K. High resolution X-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia (New York, NY) 2000, 2:62.
106. Hofmann M., Pichler B., Scholkopf B., Beyer T. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:93-104.
107. Ambrose J., Hounsfield G. Computerized transverse axial tomography. Br. J. Radiol. 1973, 46:148.
108. Chan R., He Y., Haque A., Zwischenberger J. Computed tomographic-pathologic correlation of gross tumor volume and clinical target volume in non-small cell lung cancer. Arch. Pathol. Lab. Med. 2001, 125:1469-1472.
109. Ritman E.L. Micro-computed tomography-current status and developments. Annu. Rev. Biomed. Eng. 2004, 6:185-208.
110. Badea C., Hedlund L., Johnson G. Micro-CT with respiratory and cardiac gating. Med. Phys. 2004, 31:3324.
111. Badea C.T., Fubara B., Hedlund L.W., Johnson G.A. 4-D micro-CT of the mouse heart. Mol. Imaging 2005, 4:110-116.
112. Rudin M., Weissleder R. Molecular imaging in drug discovery and development. Nat. Rev. Drug Discov. 2003, 2:123-131.
113. Antoch G., Stattaus J., Nemat A.T., Marnitz S., Beyer T., Kuehl H., Bockisch A., Debatin J.F., Freudenberg L.S. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging 1. Radiology 2003, 229:526.
114. Goerres G.W., von Schulthess G.K., Steinert H.C. Why most PET of lung and head-and-neck cancer will be PET/CT. J. Nucl. Med. 2004, 45:66S.
115. Cohade C., Osman M., Marshall L.T., Wahl R.L. PET-CT: accuracy of PET and CT spatial registration of lung lesions. Eur. J. Nucl. Med. Mol. Imaging 2003, 30:721-726.
116. Dolovich M. Measuring total and regional lung deposition using inhaled radiotracers. J. Aerosol Med. 2001, 14:35-44.
117. Gonda I. Scintigraphic techniques for measuring in vivo deposition. J. Aerosol Med. 1996, 9:59-67.
118. Singh M., Waluch V. Physics and instrumentation for imaging in-vivo drug distribution. Adv. Drug Deliv. Rev. 2000, 41:7-20.
119. Blasberg R.G., Gelovani Tjuvajev J. In vivo molecular genetic imaging. J. Cell. Biochem. 2002, 87:172-183.
120. Richard J.C., Zhou Z., Ponde D.E., Dence C.S., Factor P., Reynolds P.N., Luker G.D., Sharma V., Ferkol T., Piwnica-Worms D. Imaging pulmonary gene expression with positron emission tomography (PET). Am. J. Respir. Crit. Care Med. 2002, 200210121.
121. Piwnica Worms D., Schuster D.P., Garbow J.R. Molecular imaging of host-pathogen interactions in intact small animals. Cell. Microbiol. 2004, 6:319-331.
122. Cabeza R., Nyberg L. Imaging cognition: an empirical review of PET studies with normal subjects. J. Cogn. Neurosci. 1997, 9:1-26.
123. Dolovich M., Labiris R. Imaging drug delivery and drug responses in the lung. Am Thoracic Soc 2004, 329.
124. Milman N., Mortensen J., Sloth C. Fluorodeoxyglucose PET scan in pulmonary sarcoidosis during treatment with inhaled and oral corticosteroids. Respiration 2000, 70:408-413.
125. Lee Z., Berridge M.S., Finlay W.H., Heald D.L. Mapping PET-measured triamcinolone acetonide (TAA) aerosol distribution into deposition by airway generation. Int. J. Pharm. 2000, 199:7-16.
126. Bergstrom M., Cass L., Valind S., Westerberg G., Lundberg E.L., Gray S., Bye A., Langstrom B. Deposition and disposition of [11C] zanamivir following administration as an intranasal spray evaluation with positron emission tomography. Clin. Pharmacokinet. 1999, 36:33-39.
127. Pauwels E.K.J., McCready V.R., Stoot J.H.M.B., van Deurzen D.F.P. The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur. J. Nucl. Med. Mol. Imaging 1998, 25:277-305.
128. Mah K., Caldwell C.B., Ung Y.C., Danjoux C.E., Balogh J.M., Ganguli S.N., Ehrlich L.E., Tirona R. The impact of 18 FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 2002, 52:339-350.
129. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr. Scand. 2000, 101:11-20.
130. Erasmus J.J., Patz E.F. Positron emission tomography imaging in the thorax. Clin. Chest Med. 1999, 20:715-724.
131. Nolop K.B., Rhodes C.G., Brudin L.H., Beaney R.P., Krausz T., Jones T., Hughes J. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987, 60:2682-2689.
132. Jones H., Sriskandan S., Peters A., Pride N., Krausz T., Boobis A., Haslett C. Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis. Eur. Respir. J. 1997, 10:795.
133. Taylor I., Hayes M., O'Connor B., Jones H., Hughes J., Pride N., Hill A., O'Shaughnessy K., Rhodes C., Jones T. Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography. Lancet 1996, 347:937-940.
134. Jones H., Marino P., Shakur B., Morrell N. In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur. Respir. J. 2003, 21:567.
135. Chen D.L., Ferkol T.W., Mintun M.A., Pittman J.E., Rosenbluth D.B., Schuster D.P. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am. J. Respir. Crit. Care Med. 2006, 200506-200934OCv200501.
136. Rasey J., Koh W., Evans M., Peterson L., Lewellen T., Graham M., Krohn K. Quantifying regional hypoxia in human tumors with positron emission tomography of ['8F] fluoromisonidazole: a pretherapy study of 37 patients. Int. J. Radiat. Oncol. Biol. Phys. 1996, 36:417-428.
137. Koh W.J., Bergman K.S., Rasey J.S., Peterson L.M., Evans M.L., Graham M.M., Grierson J.R., Lindsley K.L., Lewellen T.K., Krohn K.A. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18] fluoromisonidazole positron emission tomography* 1. Int. J. Radiat. Oncol. Biol. Phys. 1995, 33:391-398.
138. Koh W.J., Rasey J.S., Evans M.L., Grierson J.R., Lewellen T.K., Graham M.M., Krohn K.A., Griffin T.W. Imaging of hypoxia in human tumors with [F-18] fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys. 1992, 22:199-212.
139. Rhodes C., Hughes J. Pulmonary studies using positron emission tomography. Eur. Respir. J. 1995, 8:1001.
140. Cherry S.R. Physics in nuclear medicine 2003, University of Wisconsin.
141. Dougall N.J., Bruggink S., Ebmeier K.P. Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am. J. Geriatr. Psych. 2004, 12:554.
142. Phipps P.R., Gonda I., Bailey D., Borham P., Bautovich G., Anderson S. Comparisons of planar and tomographic gamma scintigraphy to measure the penetration index of inhaled aerosols. Am. Rev. Respir. Dis. 1989, 139:1516.
143. Duan X.Y., Wang J.S., Liu M., Guo Y.M. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer. Ann. Nucl. Med. 2008, 22:49-55.
144. Glenny R.W. Determinants of regional ventilation and blood flow in the lung. Intensive Care Med. 2009, 35:1833-1842.
145. Beyer T., Townsend D.W., Brun T., Kinahan P.E., Charron M., Roddy R., Jerin J., Young J., Byars L., Nutt R. A combined PET/CT scanner for clinical oncology. J. Nucl. Med. 2000, 41:1369.
146. Buck A.K., Nekolla S., Ziegler S., Beer A., Krause B.J., Herrmann K., Scheidhauer K., Wester H.J., Rummeny E.J., Schwaiger M. Spect/Ct. J. Nucl. Med. 2008, 49:1305.
147. Judenhofer M.S., Wehrl H.F., Newport D.F., Catana C., Siegel S.B., Becker M., Thielscher A., Kneilling M., Lichy M.P., Eichner M. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat. Med. 2008, 14:459-465.
148. Kinahan P.E., Hasegawa B.H., Beyer T. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners 2003, 166-179. Elsevier.
149. Kinahan P., Townsend D., Beyer T., Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med. Phys. 1998, 25:2046.
150. Chen D.L., Kinahan P.E. Multimodality molecular imaging of the lung. J. Magn. Reson. Imaging 2010, 32:1409-1420.
151. Weber W.A., Grosu A.L., Czernin J. Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nat. Rev. Clin. Oncol. 2008, 5:160-170.
152. Schlemmer H.P.W., Pichler B.J., Schmand M., Burbar Z., Michel C., Ladebeck R., Jattke K., Townsend D., Nahmias C., Jacob P.K. Simultaneous MR/PET imaging of the human brain: feasibility study 1. Radiology 2008, 248:1028.
153. Bellani G., Messa C., Guerra L., Spagnolli E., Foti G., Patroniti N., Fumagalli R., Musch G., Fazio F., Pesenti A. Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study. Crit. Care Med. 2009, 37:2216.
154. Klein M., Cohen-Cymberknoh M., Armoni S., Shoseyov D., Chisin R., Orevi M., Freedman N., Kerem E. 18F-fluorodeoxyglucose-PET/CT imaging of lungs in patients with cystic fibrosis. Chest 2009, 136:1220.
155. Wachsmann-Hogiu S., Weeks T., Huser T. Chemical analysis in vivo and in vitro by Raman spectroscopy-from single cells to humans. Curr. Opin. Biotechnol. 2009, 20:63-73.
156. Krafft C., Knetschke T., Funk R.H.W., Salzer R. Studies on stress-induced changes at the subcellular level by Raman microspectroscopic mapping. Anal. Chem. 2006, 78:4424-4429.
157. Krafft C., Codrich D., Pelizzo G., Sergo V. Raman mapping and FTIR imaging of lung tissue: congenital cystic adenomatoid malformation. Analyst 2008, 133:361-371.
158. Cluff G.M., Short M.A., Lui H., McLean D.I., Zeng H., Korbelik M., Chen M.X. Comparison of connective tissue invaded by Lewis lung carcinoma to healthy connective tissue by means of micro Raman spectroscopy. J. Raman Spectrosc. 2009, 40:1087-1090.
159. Noh M.S., Jun B.H., Kim S., Kang H., Woo M.A., Minai-Tehrani A., Kim J.E., Kim J., Park J., Lim H.T. Magnetic surface-enhanced Raman spectroscopic (M-SERS) dots for the identification of bronchioalveolar stem cells in normal and lung cancer mice. Biomaterials 2009, 30:3915-3925.